Amarin Corp Plc (AMRN)

[Biobillionair]

Raf-I hope your correct. If reduction in deaths are significant this is an amazing result beyond what the Street can even manage. Currently the Street is in shock with the highest peak sales estimates of $2 b per year, this is laughable. Does the Street really think physicians will ignore cardiovascular treatment standards of care? With the results Amarin has already released, RRR 25%, AHA/ACC with have Vascepa on cholesterol guidances before end of AHA November conference. 53 million statin patients will also be on Vascepa, Amarin better work on the supply chain. If I was JT I'd be calling BASF.

This will be a volume play, but Amarin might raise the price for a year to control supply....JMO
BB